Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)

Clinical trial NCT01705626 · COMPLETED

Trial details

NCT number: NCT01705626
Sponsor: CENTOGENE GmbH Rostock
Status: COMPLETED
Study type: OBSERVATIONAL

Polyneuropathy, Amyloid Neuropathic Pain Cardiac Failure Orthostatic Hypotension Gastrointestinal Disorders

Start date: 2016-12-01
Primary completion: 2022-05-27
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.